Caesar J. Belbel
2012
In 2012, Caesar J. Belbel earned a total compensation of $1M as Executive Vice President, Chief Legal Officer and Secretary at ZIOPHARM Oncology, a 11% increase compared to previous year.
Compensation breakdown
| Bonus | $56,875 |
|---|---|
| Option Awards | $437,970 |
| Salary | $325,000 |
| Stock Awards | $219,448 |
| Other | $569 |
| Total | $1,039,862 |
Belbel received $438K in option awards, accounting for 42% of the total pay in 2012.
Belbel also received $56.9K in bonus, $325K in salary, $219.4K in stock awards and $569 in other compensation.
Rankings
In 2012, Caesar J. Belbel's compensation ranked 5,960th out of 11,487 executives tracked by ExecPay. In other words, Belbel earned more than 48.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,960 out of 11,487 | 48th |
Division Manufacturing | 2,115 out of 4,253 | 50th |
Major group Chemicals And Allied Products | 529 out of 1,203 | 56th |
Industry group Drugs | 361 out of 925 | 61st |
Industry Pharmaceutical Preparations | 285 out of 700 | 59th |
Source: SEC filing on April 30, 2014.
Belbel's colleagues
We found four more compensation records of executives who worked with Caesar J. Belbel at ZIOPHARM Oncology in 2012.